Graham Capital Management L.P. raised its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 42.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,152 shares of the real estate investment trust's stock after acquiring an additional 6,648 shares during the quarter. Graham Capital Management L.P.'s holdings in National Health Investors were worth $1,535,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of the stock. Focus Partners Wealth lifted its holdings in National Health Investors by 4.0% in the fourth quarter. Focus Partners Wealth now owns 4,867 shares of the real estate investment trust's stock valued at $337,000 after acquiring an additional 188 shares during the period. Loomis Sayles & Co. L P lifted its holdings in National Health Investors by 42.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust's stock valued at $44,000 after acquiring an additional 189 shares during the period. State of Alaska Department of Revenue lifted its holdings in National Health Investors by 1.0% in the fourth quarter. State of Alaska Department of Revenue now owns 20,040 shares of the real estate investment trust's stock valued at $1,388,000 after acquiring an additional 196 shares during the period. Pictet Asset Management Holding SA lifted its holdings in National Health Investors by 1.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 13,197 shares of the real estate investment trust's stock valued at $915,000 after acquiring an additional 238 shares during the period. Finally, Xponance Inc. lifted its holdings in National Health Investors by 9.5% in the fourth quarter. Xponance Inc. now owns 2,997 shares of the real estate investment trust's stock valued at $208,000 after acquiring an additional 259 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.
National Health Investors Price Performance
Shares of National Health Investors stock traded up $0.54 on Friday, reaching $75.16. The company's stock had a trading volume of 289,390 shares, compared to its average volume of 226,808. The company has a market capitalization of $3.51 billion, a P/E ratio of 25.83, a PEG ratio of 4.42 and a beta of 0.78. National Health Investors, Inc. has a 52-week low of $63.91 and a 52-week high of $86.13. The stock has a 50-day moving average price of $74.25 and a 200-day moving average price of $72.67. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92.
National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, topping the consensus estimate of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $68.87 million during the quarter, compared to analysts' expectations of $85.13 million. During the same period in the previous year, the business earned $1.10 earnings per share. The firm's revenue for the quarter was up 9.6% on a year-over-year basis. Analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current year.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 4.79%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's payout ratio is 114.29%.
Wall Street Analyst Weigh In
A number of analysts have recently commented on NHI shares. Wedbush restated an "outperform" rating and issued a $88.00 price objective on shares of National Health Investors in a research report on Monday, March 17th. Truist Financial boosted their price objective on National Health Investors from $70.00 to $76.00 and gave the company a "hold" rating in a research report on Wednesday, March 19th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, National Health Investors currently has an average rating of "Hold" and a consensus target price of $85.50.
Read Our Latest Report on NHI
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.